Health

Mobile Tech in Clinical Trials 10th Annual Conference to Report on the Tech that Worked for Patients During the Pandemic Organized by the Conference Forum

Leave a comment


“I am excited to be a part of this year’s meeting because the patient is truly at the center. I hope that attendees will find the inspiration, validation, and motivation to accelerate mobile technology implementation, no matter where each company is in its journey,” – Kai Bode, Merck


NEW YORK (PRWEB)

The Conference Forum announced the launch of the 10th annual Mobile Tech in Clinical Trials conference taking place September 19, 2023 in Boston at the Westin Copley Place.

For the first time, over 12 pharmaceutical companies from AbbVie to Takeda, FDA, tech companies and patient advocacy come together to discuss which technologies used in COVID-19 for remote patient participation were successful, and how these will impact the future of clinical trials.

The following pharma and biotech companies share what worked and what didn’t when they deployed digital tech during and after the pandemic:


  • AbbVie

  • BioMarin

  • BMS

  • Eli Lilly

  • Janssen

  • Merck

  • Novartis

  • Novo Nordisk

  • Otsuka

  • Roche

  • Sanofi

  • Takeda

“I am excited to be a part of this year’s meeting because the patient is truly at the center. I hope that attendees will find the inspiration, validation, and motivation to accelerate mobile technology implementation, no matter where each company is in its journey,” said Kai Bode, 2023 co-chair and Director, Digital Innovation and Patient Strategy, Global Digital Analytics & Technologies Team at Merck.

Novo Nordisk’s Head of US Digital Transformation and Innovation, Amy West, presents the 2023 Keynote with a report on the company’s digital transformation journey.

Three agencies from the FDA – The Center for Devices and Radiological Health (CDRH), Center for Biologics Evaluation and Research (CBER), Center for Drug Evaluation and Research (CDER) – to provide guidance updates and industry recommendations on prioritizing and implementing digital health tech in trials. The FDA representatives will be available for open Q&A.

“Leveraging advancements in mobile technologies has the potential to accelerate the pace of drug discovery and development and reach hard-to-get populations in trials,” said Adama Ibrahim, eMBA, 2023 co-chair and VP, Digital Strategy and Change Management at Novo Nordisk. “I look forward to hearing how our industry is using new advancements with mobile technologies in healthcare and research to benefit patients.”

The 10th annual Mobile Tech in Clinical Trials will be followed by DPHARM: Disruptive Innovations to Modernize Clinical Research, September 20-22, 2023. To learn more, visit http://www.theconferenceforum.org.

About Mobile Tech in Clinical Trials:

Mobile Tech in Clinical Trials® is the first conference, founded in 2013 to convene R&D operations and digital leaders to access, deploy and scale strategies for applying mobile/digital tools to connect and empower patients, and obtain better outcomes in drug development/clinical research. Each year, we bring forward the latest experience-based case studies while presenting fresh ideas to advance fit for purpose, adoption and scale of remote digital solutions.

About The Conference Forum:

The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. The company also publishes six newsletters and produces PharmaTalkRadio, virtual events, and webinars.

Share article on social media or email:

Leave a Reply